ANCA defines the clinical disease manifestations o...[Sarcoidosis Vasc Diffuse Lung Dis. 1996] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Click to change filter selection through MyNCBI.

1: Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct;13(3):227-9.Links

ANCA defines the clinical disease manifestations of vasculitis. The "con" side of the issue.

Mayo Clinic Scottsdale, AZ 85259, USA.

PMID: 8946587 [PubMed - indexed for MEDLINE]

Related articles

ReviewANCA defines the clinical disease manifestations of vasculitis.
Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct; 13(3):221-6.

[Sarcoidosis Vasc Diffuse Lung Dis. 1996]
[Antineutrophil cytoplasmic antibodies (ANCA). Their contribution to the pathogenesis of vasculitis]
Med Clin (Barc). 1998 Jun 6; 110(20):778-80.

[Med Clin (Barc). 1998]
Review[Diagnostic interpretation of antineutrophil cytoplasm antibodies (ANCA) in vasculitis]
Rev Clin Esp. 2000 Sep; 200(9):524-5.

[Rev Clin Esp. 2000]
ReviewSerial ANCA testing has limited value during the follow-up of disease activity in patients with ANCA-associated vasculitis.
Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct; 13(3):246-8.

[Sarcoidosis Vasc Diffuse Lung Dis. 1996]
[Anti-endothelial cell antibodies(AECA) are associated with disease activity of propylthiouracil induced antineutrophil cytoplasmic antibody (ANCA) positive vasculitis]
Beijing Da Xue Xue Bao. 2005 Aug 18; 37(4):374-7.

[Beijing Da Xue Xue Bao. 2005]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

ANCA defines the clinical disease manifestations of vasculitis. The "con" side of the issu...ANCA defines the clinical disease manifestations of vasculitis. The "con" side of the issue.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show